PharmaLundensis AB

At a glance

Most recent filing on October 4, 2025 — a sale by Tord Staffan Håkan Skogvall on Oct 1, 2025.

We hold 38 visible filings, going back to October 26, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 38 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 38. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Tord Staffan Håkan Skogvall Chief executive officer
143,164 SEKOpen-market sale
TradedOct 1, 2025FiledOct 4, 2025
Tord Staffan Håkan Skogvall Chief executive officer
17,543 SEKOpen-market buy
TradedSep 24, 2025FiledSep 25, 2025
Tord Staffan Håkan Skogvall Chief executive officer
13,131 SEKOpen-market buy
TradedSep 23, 2025FiledSep 25, 2025
Tord Staffan Håkan Skogvall Chief executive officer
13,864 SEKOpen-market buy
TradedSep 24, 2025FiledSep 25, 2025
Tord Staffan Håkan Skogvall Chief executive officer
1,986 SEKOpen-market buy
TradedMar 11, 2025FiledMar 12, 2025